NCT00309907 · OUTCOME

Estimate Percentage Pulmonary Response in Patients With IPS Treated With Etanercept + Corticosteroid Therapy

Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant · Source last updated 2017-09-29

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: NUMBER
Unit: percentage of participants
Interval / dispersion: Not reported
Time frame: up to day 56

What was measured

Pulmonary response is defined as alive \& come off of oxygen .

Analysis population: Total of 28 patients are evaluable for this outcome.

Groups in this outcome

Etanercept and Corticosteroid Therapy

Regimen A

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Etanercept and Corticosteroid Therapy	28

Reported measurements

Source class 1

Values in percentage of participants · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
Etanercept and Corticosteroid Therapy	74	Not reported	Not reported	Not reported	Not reported

Complete source fields

classes

categories
measurements
group Id
OG000
value
74

denoms

counts
group Id
OG000
value
28
units
Participants

description

Pulmonary response is defined as alive \& come off of oxygen .

groups

description
Regimen A
id
OG000
title
Etanercept and Corticosteroid Therapy

param Type

NUMBER

population Description

Total of 28 patients are evaluable for this outcome.

reporting Status

POSTED

time Frame

up to day 56

title

Estimate Percentage Pulmonary Response in Patients With IPS Treated With Etanercept + Corticosteroid Therapy

type

SECONDARY

unit Of Measure

percentage of participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice